API
AMPH icon

Advisor Partners II’s Amphastar Pharmaceuticals AMPH Stock Holding History

Advisor Partners II’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$223K Sell
4,854
-45
-0.9% -$2.46K 0.01% 1114
2023
Q2 		$282K Buy
+4,899
New +$217K 0.01% 825

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Advisor Partners II's AMPH Position: Q3 2023 in Review

Advisor Partners II reduced its Amphastar Pharmaceuticals (AMPH) stake by 0.92% in Q3 2023, selling an estimated $2.46K and leaving 4,854 shares worth $223K. The position accounts for 0.01% of the portfolio, ranked #1114.

Advisor Partners II first reported a position in AMPH in Q2 2023 and has held it in 2 quarters since. The position peaked at $282K in Q2 2023. 255 funds tracked by Wall St. Rank hold AMPH as of Q3 2023.

  • Advisor Partners II held 4,854 shares of Amphastar Pharmaceuticals worth $223K as of Q3 2023.
  • Advisor Partners II sold 45 Amphastar Pharmaceuticals shares in Q3 2023, an estimated $2.46K.
  • Amphastar Pharmaceuticals made up 0.01% of Advisor Partners II's portfolio in Q3 2023, its #1114 holding.
  • Advisor Partners II first reported a position in Amphastar Pharmaceuticals in Q2 2023 and has held it in 2 quarters since.
  • Advisor Partners II's Amphastar Pharmaceuticals position peaked at $282K in Q2 2023.
  • 255 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.